Similarly, CD163 is also expressed on alveolar macrophages, especially on M2 macrophages [100], and serum levels of soluble CD163 are significantly higher in patients with DM-ILD than in those with PM or without ILD [101]. This evidence concerns the gene CD163 and dermatomyositis.